Administration of tranexamic acid to reduce maternal mortality related to postpartum haemorrhage: comments on the WOMAN trial.

Chassard, D; Bouvet, L

Chassard, D; Bouvet, L.

Affiliation

Chassard D; Department of Anaesthesia and Intensive Care, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Bron, France; University of Lyon, Lyon, France. Electronic address: dominique.chassard@chu-lyon.fr.
Bouvet L; Department of Anaesthesia and Intensive Care, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Bron, France; University of Lyon, Lyon, France.

Int J Obstet Anesth ; 33: 89-90, 2018 02.

Article in En | MEDLINE | ID: mdl-28899732

Subject(s)

Postpartum Hemorrhage; Tranexamic Acid; Antifibrinolytic Agents; Female; Humans; Maternal Mortality; Pregnancy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tranexamic Acid / Postpartum Hemorrhage Limits: Female / Humans / Pregnancy Language: En Journal: Int J Obstet Anesth Journal subject: ANESTESIOLOGIA / OBSTETRICIA Year: 2018 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google